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Purpose: To identify clinical features and mutations within the transforming growth factor-beta-induced (TGFBI) gene
in three Chinese families with Granular corneal dystrophy, type 1 (GCD1) and Granular corneal dystrophy, type 2 (GCD2).
Methods: Clinical features of GCD1 and GCD2 in three Chinese families were studied with slit-lamp and in vivo laser
scanning confocal microscopy (LSCM). Molecular genetic analysis was performed on nine patients and fifteen unaffected
individuals from these families. All exons of TGFBI were amplified by polymerase chain reaction (PCR) and sequenced.
Results: Morphological changes in the cornea among affected individuals from three Chinese families examined by in
vivo LSCM were almost the same. A heterozygous mutation C>T (R555W) was identified in exon 12 of TGFBI in patients
of family A with GCD1. Another heterozygous mutation G>A (R124H) was found in exon 4 of TGFBI in affected members
of family B and C with GCD2.
Conclusions: Mutations R555W and R124H in TGFBI were identified in three Chinese families with GCD. Even though
there are a variety of mutations in TGFBI of GCD, the different subtypes of GCD (GCD1, GCD2, and GCD3) are in fact
the same disorder. Our work supports the hypothesis that corneal dystrophies with the common genetic basis in TGFBI
should be grouped together as TGFBI corneal dystrophies.
Corneal  dystrophies  represent  a  group  of  inherited
corneal diseases with progressive accumulation of deposits in
different  layers  of  cornea,  resulting  in  loss  of  corneal
transparency  and  visual  impairment  [1].  Identified  genes
responsible  for  corneal  dystrophies  include  transforming
growth  factor-beta-induced  (TGFBI),  carbohydrate
sulfotransferase  6  (CHST6),  gelsolin  (GSN),  keratin  3
(KRT3),  keratin  12  (KRT12),  and  chromosome  1,  surface
marker 1 (M1S1), with TGFBI mutations in human autosomal
dominant  corneal  dystrophies  being  the  most  commonly
observed.
TGFBI was first isolated in a study of genes induced by
transforming growth factor-beta (TGFβ) from a human lung
adenocarcinoma cell line in 1992 [2]. TGFBI encodes a 683
amino-acid protein containing an RGD motif (Arg-Gly-Asp)
and  four  internal  repeated  domains  which  have  highly
conserved sequences founded in several species [3]. The most
frequently reported sites of mutations are at positions 124 and
555 of TGFBIp [4], which were found to be within the fourth
fasciclin-like  domain  [5].  TGFBIp,  initially  known  as
keratoepithelin  (KE),  is  an  extracellular  matrix  protein
induced by TGFβ1. The role of  TGFBI in the pathogenesis
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of  the  chromosome  5q31-linked  corneal  dystrophies  still
remain unclear, but TGFBIp is preferentially expressed on the
extracellular  surface  of  corneal  epithelial  cells  [6]  and
pathologic deposits caused by TGFBIp accumulation were
only observed in the cornea [7].
Sharing a common genetic origin, the hereditary corneal
dystrophies linked to chromosome 5q31 and TGFBI include
Reis-Bücklers  corneal  dystrophy  (RBCD,  also  called
Granular corneal dystrophy, type 3 [GCD3]), Thiel-Behnke
corneal dystrophy (TBCD), Classic Lattice corneal dystrophy
(LCD1), Granular corneal dystrophy, type 1 (GCD1) and type
2 (GCD2) [8,9]. GCD1, also called classic Granular corneal
dystrophy, is characterized by discrete, rounded, crumb-like
opacities in the anterior stroma of the central cornea. As the
disease progresses, the lesions increase in size and number
and  may  coalesce,  extending  anteriorly  through  breaks  in
Bowman’s membrane and posteriorly to the deeper stroma
[3,10].  GCD2,  originally  known  as  Avellino  corneal
dystrophy, is featured by a combination of classic granular
and lattice dystrophies. The corneal opacities are shaped like
snowflakes, stars, or disks, together with linear opacities in
typical cases [11]. Compared to GCD1, progression of GCD2
is slower and the visual acuity is less impaired [12].
In this study, we conducted a clinical evaluation and
molecular  genetic  analysis  in  three  Chinese  families  with
GCD1 and GCD2 in southwest China.
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Patients: The study was approved by West China Hospital,
Sichuan  University  Institute  Review  Board,  Chengdu,
Sichuan Province, P.R. China. Informed consent was obtained
from all participants according to the tenets of Declaration of
Helsinki. Nine affected and fifteen unaffected individuals,
with ages ranging from 2 to 83 years old, from three unrelated
Chinese families in Sichuan Province of Southwest China
were enrolled in this study. No consanguineous marriage was
noticed in these families (Figure 1).
Clinical  examination:  All  patients  underwent
ophthalmological  examinations,  including  Snellen  best-
corrected visual acuity, detailed slit-lamp examination, and in
vivo  LSCM  (Heidelberg  Retina  Tomograph  III,  Rostock
Corneal  Module  [RCM];  Heidelberg  Engineering  GmbH,
Heidelberg, Germany).
Molecular genetic analysis: Peripheral blood was collected
from each individual involved in this study. Genomic DNA
was extracted from leukocytes using QIAamp DNA Blood
Mini Kit (Qiagen, Hilden, Germany) by standard protocols.
DNA  integrity  was  evaluated  by  1%  agarose  gel
electrophoresis.  Exons  of  TGFBI  were  amplified  from
genomic  DNA  of  each  participant  by  polymerase  chain
reaction (PCR) using the forward and reverse primers (Table
1). PCR was performed using 30 µl reaction mixtures, each
containing 30–40 ng genomic DNA, 1.0 μM of each of the
forward and reverse primers, and 15 μl of 2× Taq Master Mix
(SinoBio  Biltech  Co.  Ltd,  Shanghai,  China).  Cycling
conditions included an initial denaturation at 94 °C for 5 min,
followed by 35 cycles of denaturation at 94 °C for 30 s,
annealing at 52.6–64.3 °C for 30 s, extension at 72 °C for 30
s, and a final extension at 72 °C for 5 min. The amplified
products were purified with a cycle-pure kit (OMEGA; Bio-
Tek,  Doraville,  GA)  and  sequenced  on  the  ABI  3730XL
automated DNA sequencer (Applied Biosystems, Foster City,
CA). Nucleotide sequences were compared with the wild type
TGFBI sequence (GenBank NG_012646.1).
RESULTS
Clinical findings: Nine individuals from the three families
were diagnosed with GCD by clinical evaluation. The disease
was bilateral in all patients. In family A, the proband (patient
II:3,  Figure  1)  was  a  26-year-old  female  presented  with
recurrent photophobia. The best corrected visual acuity was
20/20 OD and 20/20 OS. The corneal examination revealed
discrete grayish dot-like opacities in the center of the cornea.
The peripheral cornea and the cornea between the opacities
remained clear (Figure 2A). The second patient from family
A (patient I:2, Figure 1) was the proband’s mother (58 years
old), who had decreased vision since the age of 40. Her best
corrected visual acuity was 20/25 OD and 20/30 OS. Slit-lamp
examination showed grayish annular and crumb-like opacities
covered almost the entire cornea of both eyes (Figure 3A).
Figure 1. Pedigrees of three Chinese families. The pedigrees showed autosomal dominant inheritance of corneal dystrophies. The closed
symbols represent subjects with GCD and the open symbols represent those who were not affected. Arrows indicate the probands. The asterisks
indicate the individuals who had undergone clinical and molecular analyses in the study.
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381In family B, the proband, a 35-year-old male (patient II:
14, Figure 1), was asymptomatic with a normal physical exam.
He had a visual acuitiy of 20/20 OD and 20/20 OS. Slit-lamp
examination revealed a few grayish irregular opacities located
in  the  anterior  corneal  stroma  (Figure  2B,C).  Slit-lamp
examination  of  another  affected  family  member  (the
proband’s sister, patient II:13, Figure 1) showed multiple star-
like and rounded opacities located in the anterior stroma of
central cornea (Figure 3E).
In family C, the proband (patient I:1, Figure 1) was an
83-year-old female who first noticed blurry vision when she
was  20  years  old.  She  had  experienced  progressive
deterioration  in  visual  acuity  bilaterally  since  then.  Her
current  best  corrected  visual  acuity  was  20/200  OD  and
20/100 OS. Slit-lamp examination revealed snowflake-like
opacities combined with linear opacities in the anterior to
middle stroma of the cornea in both eyes (Figure 2E,F). The
proband’s daughter (patient II:7, Figure 1), who was 57 years
old, exhibited more linear opacities in the cornea than the
TABLE 1. PRIMERS USED IN POLYMERASE CHAIN REACTION FOR AMPLIFICATION OF TGFBI.
Exon Primer
direction
Sequence (5′→3′) Annealing
temperature
(°C)
Product length
(bp)
1 Forward GCTTGCCCGTCGGTCGCTA 64.3 234
  Reverse TCCGAGCCCCGACTACCTGA    
2 Forward AGGCAAACACGATGGGAGTCA 60.1 204
  Reverse TAGCACGCAGGTCCCAGACA    
3 Forward CCAGATGACCTGTGAGGAACAGTGA 60.1 232
  Reverse CCTTTTATGTGGGTACTCCTCTCT    
4 Forward TCCTCGTCCTCTCCACCTGT 58.0 353
  Reverse CTCCCATTCATCATGCCCAC    
5 Forward CCTGGGCTCACGAGGGCTGAGAACAT 60.1 387
  Reverse GCCCCTCTTGGGAGGCAATGTGTCCC    
6 Forward CCTGGGCTCACGAGGGCTGAGAACAT 59.5 403
  Reverse GCCCCTCTTGGGAGGCAATGTGTCCC    
7 Forward GTGAGCTTGGGTTTGGCTTC 63.5 387
  Reverse ACCTCATGGCAGGTGGTATG    
8 Forward TGAGGTTATCGTGGAGTG 52.6 435
  Reverse CACATCAGTCTGGTCACA    
9 Forward ACTCACGAGATGACATTCCT 60.5 284
  Reverse TCCAGGGACAATCTAACAGG    
10 Forward TAGAAGATACCAGATGTTAAGG 56.1 426
  Reverse TGTCAGCAACCAGTTCTCAT    
11 Forward CCTGCTACATGCTCTGAACAA 58.0 321
  Reverse GAATCCCCAAGGTAGAAGAAAG    
12 Forward GACTCTACTATCCTCAGTGGTG 58.0 324
  Reverse ATGTGCCAACTGTTTGCTGCT    
13 Forward CATTAGACAGATTGTGGGTCA 59.9 419
  Reverse GGGCTGCAACTTGAAGGTT    
14 Forward GCGACAAGATTGAAACTCCAT 58.0 315
  Reverse CTCTCCACCAACTGCCACAT    
15 Forward CCCTCAGTCACGGTTGTT 58.0 348
  Reverse GGAGTTGCCTTGGTTCTT    
16 Forward CTTGCACAACTTATGTCTGC 58.0 319
  Reverse TGCACCATGATGTTCTTATC    
17 Forward AGTGAAGTTTCACAAACCAC 58.0 475
  Reverse CCACATTTGGGATAGGTC    
          Summary of the primers, annealing temperatures, and the predicted length for each of the PCR products is shown.
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382proband (Figure 3I). Patient II:5 (Figure 1), the 59-year-old
son  of  the  proband,  manifested  white  annular  opacities
without linear changes (Figure 2D), which is quite different
from the other patients in this family.
In vivo LSCM was performed on the subjects described
above.  Focal  deposits  of  highly  reflective  material  with
irregular  edges  were  observed  in  the  corneal  epithelium,
anterior and middle stroma (Figure 3B-D,F-H,J-L).
TGFBI  gene  analysis:  Seventeen  exons  of  TGFBI  of  the
affected and unaffected individuals were analyzed by direct
sequencing.  In  family  A,  a  heterozygous  mutation  C>T
transversion in exon 12 was identified in each patient, which
resulted in an amino acid substitution from Arginine (CGG)
to Tryptophan (TGG) at codon 555 (R555W). In family B and
C, a heterozygous mutation T>A in exon 4 was identified in
each patient, which caused an amino acid substitution from
Arginine (CGC) to Histidine (CAC) at codon 124 (R124H;
Figure 4). No mutation was found in the unaffected members
in these families.
DISCUSSION
Bilateral corneal dystrophy includes a group of genetically
determined, non-inflammatory corneal diseases, which result
in loss of corneal transparency and visual impairment [8,13].
In general, the dystrophies can be categorized according to the
specific  layer  of  cornea  mainly  affected;  epithelial,
subepithelial,  Bowman’s  layer,  stromal,  and  endothelial
dystrophies [14-17]. In this study, nine patients from three
Chinese  families  presented  with  gray-white  opacities  in
epithelial, subepithelial and anterior to middle stroma of both
eyes.  Thus,  hereditary  corneal  dystrophies  with  atypical
characteristics that affect multiple corneal layers can not be
classified to a single type based on morphologic criteria [18].
The progress of molecular genetic analysis has deepened our
understanding  of  the  corneal  dystrophies  and  showed  the
limitations  of  the  current  phenotypic  method  of  corneal
dystrophy classification. Since 1994 three types of autosomal
dominant corneal dystrophies and TGFBI were mapped to
chromosome 5 (5q31) [19,20], more than 30 mutations in
TGFBI have been identified to be associated with corneal
dystrophies with distinct subtypes being confirmed [17,19].
Mutations in varied genes can result in a single phenotype,
whereas different defects in a single gene can cause various
phenotypes. The IC3D Classification of Corneal Dystrophies,
which  incorporates  many  aspects  of  the  conventional
definitions of corneal dystrophies with new genetic, clinical,
and  pathologic  information,  provides  a  more  accurate
approach to classify corneal dystrophies including those with
low likelyhood to have a genetic basis [8].
Figure 2. Slit-lamp photomicrographs. In family A, discrete dot opacities in the central cornea of the right eye were noted in the proband
(A). In family B, the right eye of the proband showed a few grayish irregular and rounded corneal opacities (B and C). The peripheral cornea
and the cornea between the opacities remained clear. In family C, the image of patient II:5 revealed scattered annular opacities (D). The
proband presented with snowflake-like opacities combined with a linear opacity (E and F).
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383Figure 3. Representative images of affected members in the three families were compared by slit-lamp examination and in vivo LSCM. A-
D: patient I:2 from family A; E-H: patient II:13 from family B; I-L: patient II:7 from family C. The eye of the proband’s mother revealed
grayish annular and crumb-like opacities covered almost the entire cornea (A). The image of the proband’ sister showed multiple star-like and
rounded opacities occupying the central cornea (E). The eye of the proband’s daughter presented with typical snowflake-like opacities
combined with linear opacities (I). Focal deposits of reflective material with irregular edges were observed at different levels by LSCM. The
images represented 23 μm (B, F, J), 45 μm (C, G, K), and 96 μm (D, H, L) from the corneal surface.
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384Figure 4. TGFBI heterozygous mutations in family A, B, and C. A: Unaffected individuals, no mutation was identified (black arrow). B:
Patients in family A. A heterozygous mutation consisting of a C>T transversion in exon 12 (red arrow) was observed. C and E: Unaffected
individuals, no mutation was detected (black arrow). D and F: The sequence in affected members in family B and C showed a heterozygous
G>A transversion (indicated by the red arrow) was observed.
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385TGFBI  is  known  to  play  a  significant  role  in  the
pathogenic mechanism of most autosomal dominant corneal
dystrophies  including  GCD1,  GCD2,  LCD1,  RBCD,  and
TBCD. In our study, the affected members from family B and
C were confirmed to share the same genetic mutation (R124H)
in TGFBI. The patients from family B presented with atypical
phenotype of GCD2, as their cornea had star-like and rounded
opacities  only  (no  linear  opacities  noticed),  whereas  the
patients from family C manifested both typical and atypical
phenotypes of GCD2. These observations indicate that GCD2
appears to be phenotypically variable and can be difficult to
distinguish from GCD1 [12]. Clinical diagnosis of different
types of corneal dystrophy is difficult, especially for GCD1
and  GCD2.  Molecular  genetic  analysis  is  required  for
subclassification of corneal dystrophies [21]. Identifying the
causative  gene  is  considerately  significant  to  understand
corneal disease not only for proper classification but also for
prenatal  diagnosis,  accurate  genetic  counseling,  or  gene
therapy [22].
LSCM, which is a non-invasive and real-time spatial
sectioning of corneal tissues at the cellular level, was used in
this  study  to  better  characterize  corneal  dystrophies  and
enhance our understanding of the clinical characteristics of
different phenotypes of GCD. Previous study have shown that
in GCD2, highly reflective granular materials with irregular
edges  were  observed  in  the  superficial  stroma.  In  LCD1,
highly reflective branching filaments of variable width were
observed in the stroma. In macular corneal dystrophy (MCD),
homogeneous reflective materials with dark striaelike images
were  observed  throughout  the  stroma  [23].  In  our  study,
morphological studies of the GCD subjects from the three
Chinese  families  under  LSCM  revealed  focal  deposits  of
reflective material with irregular edges at different layers of
cornea.  We  previously  reported  the  R124C  mutation  in
TGFBI in RBCD (also known as GCD3) in a Chinese pedigree
[24].  The  results  obtained  from  that  pedigree  and  three
pedigrees in this study suggested that even though clinical
appearances under slit-lamp examination were different in
these families, the morphological features of cornea deposits
examined by LSCM were almost the same. For example, the
irregular materials with high reflectivity in the epithelial basal
layer in GCD3 [24] are similar to those observed in this study
in GCD1 and GCD2 in both morphological features and laser
light reflectivity. This illustrates that, even though there are a
variety of mutations in TGFBI responsible for pathogenesis
of GCD, the different subtypes (GCD1, GCD2, and GCD3)
are in fact the same disorder.
Although the causative genes have been identified, the
molecule mechanism and the pathogenesis of the diseases still
remain to be illustrated. It was shown that mRNA of TGFBI
is expressed in various organs and tissues [6]. The mutant
TGFBIp deposits were only found in the cornea but not in
other tissue of patients with corneal dystrophies [7], indicating
that specific conditions existing in the cornea is responsible
for the accumulation of mutated TGFBIp. Local factors may
influence the TGFBIp amyloidogenesis [25]. Kim et al. [26]
reported that periostin accumulated in deposits of aggregated
mutant TGFBIp, suggesting that TGFBIp and periostin may
play cooperative cellular roles in the pathogenesis of 5q31-
linked corneal dystrophies. Furthermore, the study of mutated
TGFBIp  structure  showed  that  the  common  mutations  of
TGFBI at mutation hotspots (positions 124 and 555) were
likely to affect protein–protein interactions, whereas the rare
mutations were inclined to cause misfolding of the protein
within the cell [27]. In 1992, Korvatska [1] reported that two
mechanisms of TGFBIp misfolding (amyloid and nonamyloid
deposits) were implicated in the pathogenesis of the disease.
The mutated TGFBIp comprised all kinds of pathological
deposits;  amyloid  fibrils  in  LCD1  and  non-amyloid
amorphous accumulation in GCD1 and GCD3. GCD2, is a
mixed  form,  containing  both  amyloid  and  nonamyloid
aggregates [28]. The molecular basis underlying the formation
of amyloid and/or nonamyloid accumulation is still unclear,
and worthy of further studies.
In  conclusion,  this  study  elucidated  the  correlation
between  genotype  and  phenotype  of  GCDs.  Our  work
supports  the  hypothesis  that  corneal  dystrophies  with  the
common genetic basis of TGFBI should be grouped together
as TGFBI corneal dystrophies [8]. Obviously, more large
pedigrees with GCD are needed in further investigations.
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